Status:
WITHDRAWN
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate flexible doses (5-30 mg) of aripiprazole in patients with bipolar depression.
Eligibility Criteria
Inclusion
- Outpatients
- Must sign informed consent prior to protocol-related procedures
Exclusion
- Women who are pregnant, trying to become pregnant, or nursing
- Significant risk of committing suicide
- Any serious unstable medical conditions
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00338273
Start Date
December 1 2006
End Date
November 1 2007
Last Update
November 8 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Durham, North Carolina, United States
2
Local Institution
Ahmedabad, Gujarat, India
3
Local Institution
Chennai, India
4
Local Institution
Delhi, India